InvestorsHub Logo
Followers 0
Posts 1200
Boards Moderated 0
Alias Born 05/05/2017

Re: FDApproved post# 18530

Saturday, 11/17/2018 6:47:38 PM

Saturday, November 17, 2018 6:47:38 PM

Post# of 44784
So... Why do you think Sagilon can make the case for the value and potential of their portfolio with pre-clinical data to Eli Lilly, arguably the most conservative, sedimentary of all the big pharmas and PSTI can't sell 'the cure' and 'anti-aging' formula to 'anyone' with all of the Phase II/III data we have?!?!?!?!

ONE WORD, Leadership.